Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

BACKGROUND: Little is known about the applicability of dual treatments based on integrase inhibitors. We explored the combination of lamivudine + dolutegravir as an option when switching from standard cART in virologically suppressed patients. METHODS: In this prospective cohort we enrolled patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggiolo, Franco, Gulminetti, Roberto, Pagnucco, Layla, Digaetano, Margherita, Benatti, Simone, Valenti, Daniela, Callegaro, Annapaola, Ripamonti, Diego, Mussini, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356275/
https://www.ncbi.nlm.nih.gov/pubmed/28302065
http://dx.doi.org/10.1186/s12879-017-2311-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356275/
https://www.ncbi.nlm.nih.gov/pubmed/28302065
http://dx.doi.org/10.1186/s12879-017-2311-2

Ejemplares similares